Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Clay Douglass
Mar 29, 2023 9:43AM ET
Biden is a pos bum that caused it all.
4
4
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🚨 NDVA surged 43% - these 3 AI stocks could be next Start Free Trial
7 analyst cuts of the day: Fox cut down at BofA | Pro Recap
Published Mar 29, 2023 05:46AM ET
Updated Mar 29, 2023 07:31AM ET
© Reuters.
By Davit Kirakosyan
Investing.com -- Here is your daily Pro Recap of the biggest analyst downgrades and sell initiations you may have missed since yesterday.
Fox cut to Neutral from Buy at BofA
BofA Securities downgraded Fox (NASDAQ:FOXA) to Neutral from Buy and cut its price target to $34.00 from $42.00.
Shares were down more than 2% yesterday.
As always, InvestingPro subscribers got this news first. Start your free 7-day trial to get on board.
Medtronic initiated at Sell
A new analyst at UBS assumed coverage on Medtronic (NYSE:MDT) with a Sell rating and $79 price target, noting it lacks conviction that the company can return to sustainable mid-single-digit top-line growth and drive consistent operating margin upside, despite the company's ongoing transformation.
CFRA initiates XPeng with a Sell rating, expects relatively small players to face difficulties
CFRA initiated coverage on Xpeng (NYSE:XPEV) with a Sell rating and a price target of $8.00.
While the firm expects XPeng's revenue momentum to sustain, driven by rising demand for electric vehicles, it believes competition will rise aggressively in the next 2-3 years, given more traditional brands (e.g., Toyota, Volkswagen, and Ford) are rapidly rolling out their respective EV models, as well as threats from well-established Chinese EV brands (e.g., Li Auto, BYD, and Geely).
"We expect relatively small players like XPeng to face difficulties in expanding market share organically after the pent-up demand tapers. This becomes additionally challenging as industry peers are cutting prices to boost sales volume," said the firm.
Ciena downgraded at Morgan Stanley
Morgan Stanley downgraded Ciena (NYSE:CIEN) to Equalweight from Overweight and cut its price target to $57.00 from $59.00.
Meanwhile, Raymond James upgraded the stock to Strong Buy on the expected new market entry. Shares rose more than 4% yesterday.
3 more downgrades
Société Générale downgraded Merck (NYSE:MRK) to Hold from Buy.
BofA Securities downgraded iHeartMedia (NASDAQ:IHRT) to Underperform from Neutral and cut its price target to $4.00 from $6.50. Shares plunged more than 11% yesterday.
Goldman Sachs downgraded Delek US Energy (NYSE:DK) to Neutral from Buy and cut its price target to $24.00 from $36.00.
Related Articles
Comments (3)
Sam F
Mar 29, 2023 9:43AM ET
But not as bad as the orange monster who thinks nothing of getting his cult to commit insurrection when he loses elections or gets charged with crimes he committed.
0
0
Derick Lim
Mar 29, 2023 9:25AM ET
These downgraded companies should hire more sock puppet analysts to spew manipulative news to push up the stocks and IB upgrading........like Meta, or Micron
3
0
احمد القحطاني
Mar 29, 2023 9:20AM ET
hai
1
0
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.